FDA approves Perioperative Imfinzi Regimen for muscle-invasive bladder cancer
.thumb.png.ea12d62fcb43a79b1d7a7a4664107cbc.png)
Entry posted by ADMIN
14 views
FDA approves Perioperative Imfinzi Regimen for muscle-invasive bladder cancerThe FDA has approved AstraZeneca’s Imfinzi in combination with enfortumab vedotin as neoadjuvant treatment, followed by Imfinzi monotherapy after surgery, for adults with muscle-invasive bladder cancer who...
0
0 Comments
Recommended Comments
There are no comments to display.
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.